SpaceX IPO launches today. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAccsys Tech Regulatory News (AXS)

Share Price Information for Accsys Tech (AXS)

Share Price is delayed by 15 minutes
Get Live Data
77.00    0.00 (0.00%)
Bid:
77.00
Ask:
78.20
Spread: 1.20 (1.558%)
Market Cap: £187.07m
AXS Live PriceLast checked at - London Stock Exchange

Intraday Accsys Tech Share Chart

Directors' Interests

5 Jul 2012 16:16

RNS Number : 0480H
Accsys Technologies PLC
05 July 2012
 



AIM: AXS

NYSE Euronext Amsterdam: AXS

5 July 2012

 

ACCSYS TECHNOLOGIES PLC("Accsys" or "the Company")

 

Directors' Interests

 

The Company announces that in connection with employee remuneration and incentivisation arrangements and in respect of the period from 1 July 2011 to 30 June 2012, following recommendation from the nomination and remuneration committee of the Company, the Board has resolved to issue Ordinary Shares to an Employee Benefit Trust, the beneficiaries of which include executive Directors.

 

Such Ordinary Shares shall vest if the employees, including the executive Directors, remain in employment with the Company to the vesting date, being 1 July 2013 (subject to certain other provisions including good-leaver, take-over and committee discretion provisions).

 

A total of 3,926,666 Ordinary Shares will be issued to the Employee Benefit Trust, of which 2,166,666 relate to the executive Directors as set out below:

 

Name Number Number of Ordinary Shares

Paul Clegg 1,500,000

Hans Pauli 666,666

 

All Ordinary Shares will be issued pending admission to trading on AIM and Euronext which is expected to take place on 6 July 2012.

 

The issued share capital of the Company following admission will be 407,943,308.

 

Ends

 

For further information, please contact:

 

Accsys Technologies PLC

Paul Clegg, CEO

Hans Pauli, CFO

 via Citigate Dewe Rogerson

Numis Securities

Nominated Adviser: Oliver Cardigan

Corporate Broking: Christopher Wilkinson

Ben Stoop

+44 (0)20 7260 1000

 

Citigate Dewe Rogerson

Ginny Pulbrook

Malcolm Robertson

Suzanne Bakker

+44 20 7282 2945

+44 20 7282 2867

+31 20 575 4023

 

Notes to Editors:

Accsys Technologies PLC(www.accsysplc.com) is an environmental science and technology company whose primary focus is on the production of Accoya® wood and technology licensing via its subsidiary, Titan Wood Limited, which has manufacturing operations in Arnhem, the Netherlands (through its subsidiary Titan Wood B.V.), a European office in Windsor, United Kingdom, and an American office in Dallas, Texas (via its subsidiary Titan Wood, Inc). All group subsidiaries are ultimately 100% owned by Accsys and trade as Accsys Technologies. Any references in this announcement to agreements with Accsys shall mean agreements with either Accsys or its subsidiary entities unless otherwise specified. Accsys Technologies PLC is listed on the London Stock Exchange AIM market and on Euronext Amsterdam by NYSE Euronext, under the symbols 'AXS'. Accsys' operations comprise three principal business units: (i) Accoya® wood production; (ii) technology development, focused on a programme of continuous development of and improvements to the process engineering and operating protocols for the acetylation of solid wood and the development of technology for the acetylation of wood elements; and (iii) the licensing of technology for the production of Accoya® wood and Tricoya® wood elements across the globe.

Accoya® wood (www.accoya.com) is produced using Accsys' proprietary patented acetylation technology, that effectively converts sustainably grown softwoods and non-durable hardwoods into what is best described as a "high technology wood". Distinguished by its durability, dimensional stability and, perhaps most importantly of all, its reliability (in terms of consistency of both supply and quality), Accoya® wood is particularly suited to exterior applications where performance and appearance are valued. Unlike most tropical and European hardwoods, its colour does not degrade when exposed to ultraviolet light. Moreover, the Accoya® wood production process does not compromise the wood's strength or machinability. The combination of UV resistance, dimensional stability, durability and retained strength means that Accoya® wood offers a wealth of new opportunities to architects, designers and specifiers. For marine uses where weight is also important, Accoya® wood for the first time provides boat builders with a wood that is strong, lightweight, durable and retains its natural beauty for far longer. For a full archive of Accoya® news, visit www.accoya.com/news.asp.

Wood Acetylation is a process which increases the amount of 'acetyl' molecules in wood, thereby changing its physical properties. The process protects wood from rot by making it "inedible" to most micro-organisms and fungi, without - unlike conventional treatments - making it toxic. It also greatly reduces the wood's tendency to swell and shrink, making it less prone to cracking and ensuring that, when painted, it requires dramatically reduced maintenance.

 

 

Accoya®, Tricoya®, the Trimarque Device and the Elements logo are registered trademarks owned by Titan Wood Limited and may not be used or reproduced without written permission.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSEASXSEFLAEFF
Date   Source Headline
25th Jul 20184:58 pmRNSNotifiable Interest - Teslin Participaties
25th Jul 20184:51 pmRNSHolding(s) in Company
19th Jul 20187:00 amRNSNotifiable Interest - Teslin Participaties
18th Jul 20187:08 amRNSVP Participaties BV Issue of Shares
29th Jun 20184:25 pmRNSTotal Voting Rights
19th Jun 20185:00 pmRNSDirectors Interest EBT LTIP
19th Jun 20187:00 amRNSPreliminary Announcement
2nd May 20187:00 amRNSTrading Update Year Ending March 2018
1st May 20187:00 amRNSPurchase of Arnhem land and buildings
18th Apr 201810:21 amRNSNotifiable Interest - Teslin Participaties
3rd Apr 20187:00 amRNSNotifiable Interest - Teslin Participaties
16th Mar 20187:00 amRNSTricoya® licence agreement completed with FINSA
28th Feb 20182:20 pmRNSTotal Voting Rights
23rd Feb 20183:05 pmRNSIssue of Equity
6th Feb 20187:00 amRNSBoard Appointment
4th Jan 20184:01 pmRNSNotifiable Interest - Royal Bank of Canada
20th Dec 20172:23 pmRNSNotifiable Interest - Teslin
13th Dec 201710:52 amRNSNotifiable Interest - Decico
24th Nov 20179:34 amRNSNotifiable Interest - Decico
22nd Nov 20177:00 amRNSInterim Results for period ending 30 September 17
18th Oct 20171:18 pmRNSNotifiable Interest - Decico BV
12th Oct 20178:34 amRNSNotifiable Interest - Ineos
29th Sep 20174:00 pmRNSTotal Voting Rights
22nd Sep 20174:20 pmRNSDirectors Interest EBT LTIP
21st Sep 20175:09 pmRNSAGM Proxy Results
21st Sep 20177:00 amRNSAGM Statement
5th Sep 20172:36 pmRNSNotifiable Interest - Teslin
17th Aug 20175:11 pmRNSAGM Notification
18th Jul 20174:12 pmRNSNotifiable Interest - Teslin Participaties
12th Jul 20175:28 pmRNSEmployee Benefit Trust and Directors Interests
7th Jul 20177:00 amRNSNotifiable Interest - Todlin
6th Jul 20176:33 pmRNSNotifiable Interest - Teslin Participaties
30th Jun 201710:13 amRNSTotal Voting Rights
20th Jun 20174:28 pmRNS20170620 - Directors Interest EBT LTIP
20th Jun 20177:00 amRNSPreliminary Results
27th Apr 20175:19 pmRNSNotifiable Interest - Ineos Industries Holdings
27th Apr 20175:17 pmRNSNotifiable Interest - OP Group Central Cooperative
26th Apr 20171:32 pmRNSNotifiable Interest - OP Group Central Cooperation
26th Apr 20179:56 amRNSNotifiable Interest - FIL
25th Apr 20172:01 pmRNSNotifiable Interest - Todlin N.V.
24th Apr 20175:59 pmRNSDirector Dealings
24th Apr 20177:45 amRNSTotal Voting Rights
24th Apr 20177:00 amRNSTrading Update
21st Apr 201711:52 amRNSSuccessful Result of Firm Placing, Open offer & GM
29th Mar 20177:02 amRNSTricoya® Project, funding and equity raise
29th Mar 20177:00 amRNSTrading Update
28th Feb 201712:14 pmRNSTotal Voting Rights
3rd Feb 20173:56 pmRNSAccsys Employee Share Participation Plan
22nd Nov 20167:00 amRNSInterim results
30th Sep 20165:00 pmRNSHome Member State

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.